Study of role of certain blood tests in predicting the severity of ovarian cancer
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2021/06/034317
- Lead Sponsor
- TATA main hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All new cases of ovarian malignancy
Exclusion Criteria
Patients with borderline ovarian tumors
2.clinical evidence of infection or other inflammatory conditions
3. Secondary malignancy or multiple primary malignancies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method association between CRP/albumin ratio and clinicopathological factors- <br/ ><br>Age, tumor stage and grade, histological features, ascites, lymph node involvement, tumor markersTimepoint: October 2022
- Secondary Outcome Measures
Name Time Method Comparison between predictive ability of CRP/albumin ratio and CA-125Timepoint: October 2022